Oncolytics Biotech Inc
(MENAFN- Baystreet) 01:52 PM EST - Oncolytics Biotech Inc: Provides an update on its intellectual property strategy, outlining progress on new method of use patents and plans to expand its portfolio with composition of matter protection for a modified“next generation” pelareorep. These initiatives build on the Company's existing manufacturing patent protection through 2044 and are intended to extend protection for specified therapeutic uses and future innovations into the late 2040s, subject to patent issuance and applicable patent terms. Oncolytics Biotech Inc
shares N are trading off one cent at $0.46.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment